Motor protein Kif6 regulates cilia motility and polarity in brain ependymal cells.
Takagishi M, Yue Y, Gray RS, Verhey KJ, Wallingford JB., Free PMC Article

KIF6 Trp719Arg Genetic Variant Increases Risk for Thoracic Aortic Dissection.
Velasco JJ, Li Y, Ziganshin BA, Zafar MA, Rizzo JA, Ma D, Zang H, Kalyanasundaram A, Elefteriades JA., Free PMC Article

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention.
Barbieri L, Verdoia M, Suryapranata H, Carugo S, De Luca G., Free PMC Article

Are KIF6 and APOE polymorphisms associated with power and endurance athletes?
Wojciechowicz B, Laguette MN, Sawczuk M, Humińska-Lisowska K, Maciejewska-Skrendo A, Ficek K, Michałowska-Sawczyn M, Leońska-Duniec A, Kaczmarczyk M, Chycki J, Trybek G, September AV, Cięszczyk P.

Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls.
Li Y, Chen Z, Song H., Free PMC Article

Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.
Angelini S, Rosticci M, Massimo G, Musti M, Ravegnini G, Consolini N, Sammarini G, D'Addato S, Rizzoli E, Botbayev D, Borghi C, Cantelli-Forti G, Cicero AF, Hrelia P., Free PMC Article

The Trp719Arg polymorphism of the KIF6 gene and coronary heart disease risk: systematic review and meta-analysis.
Ruiz-Ramos D, Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop I, López-Narváez ML, González-Castro TB, Torres-Hernández ME, Baños-González MA., Free PMC Article

Investigation of KIF6 Trp719Arg gene polymorphism in a case-control study of coronary artery disease and non-fatal myocardial infarction in the Eastern Province of Saudi Arabia.
Vatte C, Cyrus C, Al Shehri AM, Chathoth S, Almansori M, Al-Nafaie A, Al-Ali R, Al-Muhanna F, Asselbergs FW, Al-Ali A., Free PMC Article

Impact of KIF6 Polymorphism rs20455 on Coronary Heart Disease Risk and Effectiveness of Statin Therapy in 100 Patients from Southern Iran.
Hamidizadeh L, Haji Hosseini Baghdad Abadi R, Babaee Baigi MA, Dastsooz H, Khazaei Nejhad A, Fardaei M.

Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men.
Wu G, Li GB, Dai B, Zhang DQ., Free PMC Article

Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect.
Peng P, Lian J, Huang RS, Xu L, Huang Y, Ba Y, Yang X, Huang X, Dong C, Zhang L, Ye M, Zhou J, Duan S., Free PMC Article

Association of KIF6 variant with lipid level and angiographic coronary artery disease events risk in the Han Chinese population.
Wu G, Li GB, Dai B., Free PMC Article

KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
Liu X, Gomez-Pinillos A, Loder C, Carrillo-de Santa Pau E, Qiao R, Unger PD, Kurek R, Oddoux C, Melamed J, Gallagher RE, Mandeli J, Ferrari AC., Free PMC Article

A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: two meta-analyses and a meta-regression analysis.
Ference BA, Yoo W, Flack JM, Clarke M., Free PMC Article

KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.
Akao H, Polisecki E, Kajinami K, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J, Packard C, Buckley BM, Schaefer EJ.

Investigation of KIF6 Trp719Arg in a case-control study of coronary artery disease in Western Indians.
Bhanushali AA, Contractor A, Shah VT, Das BR.

Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D study.
Hoffmann MM, März W, Genser B, Drechsler C, Wanner C.

[Association of a polymorphic marker Trp719Arg of KIF6 gene with effects of atorvastatin and simvastatin in patients with early ischemic heart disease].
Koroleva OS, Pushkov AA, Blagodatskikh KA, Baranova OA, Azizova OA, Nosikov VV, Reznichenko NE, Zateĭshchikov DA.

The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.
Shiffman D, O'Meara ES, Rowland CM, Louie JZ, Cushman M, Tracy RP, Devlin JJ, Psaty BM., Free PMC Article

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
Hopewell JC, Parish S, Clarke R, Armitage J, Bowman L, Hager J, Lathrop M, Collins R, MRC/BHF Heart Protection Study Collaborative Group.

Investigation of KIF6 Trp719Arg in a case-control study of myocardial infarction: a Costa Rican population.
Bare LA, Ruiz-Narvaéz EA, Tong CH, Arellano AR, Rowland CM, Catanese JJ, Sacks FM, Devlin JJ, Campos H., Free PMC Article

Genetic variants in the KIF6 region and coronary event reduction from statin therapy.
Li Y, Sabatine MS, Tong CH, Ford I, Kirchgessner TG, Packard CJ, Robertson M, Rowland CM, Bare LA, Shepherd J, Devlin JJ, Iakoubova OA., Free PMC Article

KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy.
Li Y, Iakoubova OA, Shiffman D, Devlin JJ, Forrester JS, Superko HR.

[Motor protein Kinesin-6 and ischemic heart disease].
Koroleva OS, Zateĭshchikov DA.

Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies.
Assimes TL, Hólm H, Kathiresan S, Reilly MP, Thorleifsson G, Voight BF, Erdmann J, Willenborg C, Vaidya D, Xie C, Patterson CC, Morgan TM, Burnett MS, Li M, Hlatky MA, Knowles JW, Thompson JR, Absher D, Iribarren C, Go A, Fortmann SP, Sidney S, Risch N, Tang H, Myers RM, Berger K, Stoll M, Shah SH, Thorgeirsson G, Andersen K, Havulinna AS, Herrera JE, Faraday N, Kim Y, Kral BG, Mathias RA, Ruczinski I, Suktitipat B, Wilson AF, Yanek LR, Becker LC, Linsel-Nitschke P, Lieb W, König IR, Hengstenberg C, Fischer M, Stark K, Reinhard W, Winogradow J, Grassl M, Grosshennig A, Preuss M, Schreiber S, Wichmann HE, Meisinger C, Yee J, Friedlander Y, Do R, Meigs JB, Williams G, Nathan DM, MacRae CA, Qu L, Wilensky RL, Matthai WH Jr, Qasim AN, Hakonarson H, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Knouff CW, Waterworth DM, Walker MC, Mooser VE, Marrugat J, Lucas G, Subirana I, Sala J, Ramos R, Martinelli N, Olivieri O, Trabetti E, Malerba G, Pignatti PF, Guiducci C, Mirel D, Parkin M, Hirschhorn JN, Asselta R, Duga S, Musunuru K, Daly MJ, Purcell S, Eifert S, Braund PS, Wright BJ, Balmforth AJ, Ball SG, Myocardial Infarction Genetics Consortium, Wellcome Trust Case Control Consortium, Cardiogenics, Ouwehand WH, Deloukas P, Scholz M, Cambien F, Huge A, Scheffold T, Salomaa V, Girelli D, Granger CB, Peltonen L, McKeown PP, Altshuler D, Melander O, Devaney JM, Epstein SE, Rader DJ, Elosua R, Engert JC, Anand SS, Hall AS, Ziegler A, O'Donnell CJ, Spertus JA, Siscovick D, Schwartz SM, Becker D, Thorsteinsdottir U, Stefansson K, Schunkert H, Samani NJ, Quertermous T., Free PMC Article